RGR 37.42 Sturm Ruger & Company $RGR Hit a 52 week low of

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
RGR 37.42 Sturm Ruger & Company $RGR Hit a 52 week low of 37.00 Closing the day 11/06/14 at 37.42 -0.40 -1.06% With a day low of 37.00 and a total volume of 313,878.

RGR Recent Posts: http://investorshangout.com/Sturm-Ruger--Company-RGR-52519/

RGR Sturm Ruger & Company Recent Headline News

Tomorrow's Ex-Dividends To Watch: ELP, RGR, WETF
at The Street - Thu Nov 06, 9:06AM CST
ELP RGR WETF are going ex-dividend tomorrow, Friday, November 07, 2014
WETF: 15.71 (+0.31), ELP: 13.17 (-0.54), RGR: 37.42 (-0.40)

Sturm Ruger (RGR) Downgraded From Buy to Hold
at The Street - Wed Nov 05, 8:31AM CST
Sturm Ruger RGR has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+. TheStreet Ratings Team has this to say about their recommendation:
RGR: 37.42 (-0.40)

NYSE stocks posting largest percentage decreases
AP - Thu Oct 30, 12:17PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on New York Stock Exchange at 1 p.m.:
ORB: 24.23 (+0.05), AEM.TO: 26.41 (+1.24), CLV: 10.33 (-0.28), NKA: 5.95 (+0.19), CLF: 10.54 (-0.61), ATK: 109.34 (+0.48), LRN: 12.21 (+0.57), THO.TO: 18.00 (-0.28), RCAP: 10.97 (-0.61), MYE: 15.41 (+0.04), AEM: 23.12 (+0.91), TRN: 35.05 (+0.93), TEX: 28.67 (+0.98), TAHO: 15.76 (-0.28), WNC: 10.55 (+0.24), RGR: 37.42 (-0.40), WTW: 25.32 (+0.07), BCO: 21.48 (+0.14)

Is Sturm Ruger & Company a Good Sin Stock to Buy?
Leo Sun, The Motley Fool - Motley Fool - Thu Oct 30, 8:30AM CDT
"Sin stocks" are often considered a safe haven for investors when the market gets frothy. While most people immediately think of tobacco, alcohol, or casino stocks as fitting into this group, they also include firearm stocks. There are only two...
RGR: 37.42 (-0.40), SWHC: 10.06 (-0.10)

Sturm Ruger posts 3Q profit
Automated Insights - Thu Oct 30, 4:04AM CDT
SOUTHPORT, Conn. (AP) _ Sturm Ruger & Co. (RGR) on Thursday reported earnings of $6.8 million, or 34 cents per share, in its third quarter.
RGR: 37.42 (-0.40)

Sturm, Ruger & Company Q3 Earnings Badly Miss the Mark
Steve Symington, The Motley Fool - Motley Fool - Wed Oct 29, 5:51PM CDT
Sturm, Ruger & Company may make accurate firearms, but its third-quarter results missed analysts' targets by a mile. Shares of Ruger fell more than 8% in Wednesday's after-hours trading when it announced that quarterly revenue fell 42.5% year...
RGR: 37.42 (-0.40), SWHC: 10.06 (-0.10)

Sturm, Ruger & Company, Inc. Reports Third Quarter Fully Diluted Earnings of 34¢ Per Share and Declares Dividend of 14¢ Per Share
Business Wire - Wed Oct 29, 4:05PM CDT
Sturm, Ruger & Company, Inc. (NYSE-RGR) announced today that for the third quarter of 2014 the Company reported net sales of $98.3 million and fully diluted earnings of 34¢ per share, compared with net sales of $170.9 million and fully diluted earnings of $1.44 per share in the third quarter of 2013.
RGR: 37.42 (-0.40)

Stocks Rebound After Extending Losses
at Investor's Business Daily - Wed Oct 29, 2:09PM CDT
Stocks pared losses after stumbling to new session lows after the Federal Reserve ended its latest round of quantitative easing. The Nasdaq cut a 1% loss to 0.5%, while the S&P 500 shaved an 0.8% deficit to 0.4%. The Dow Jones industrial average was...
CAVM: 52.29 (+0.04), EXR: 58.28 (-0.27), PRAA: 62.77 (-0.94), VDSI: 26.49 (+0.57), V: 250.09 (+0.56), BIDU: 236.90 (-0.80), TRN: 35.05 (+0.93), FFIV: 125.21 (-0.21), CAR: 57.47 (+0.64), TRLA: 42.49 (-1.80), RGR: 37.42 (-0.40), SLCA: 41.79 (+0.89), SIMO: 24.23 (+0.60), BABA: 111.57 (+2.90)

Sturm, Ruger & Company, Inc. to Report Third Quarter Results and File Quarterly Report on Form 10-Q on Wednesday, October 29
Business Wire - Tue Oct 28, 4:05PM CDT
Sturm, Ruger & Company, Inc. (NYSE:RGR) will file its Quarterly Report on Form 10-Q on Wednesday, October 29, 2014, after the close of the stock market.
RGR: 37.42 (-0.40)

Sigmetrix, LLC Announces Sale of Tolerance Analysis Solution to Sturm, Ruger & Co., Inc.
PRWeb - Tue Oct 21, 7:02AM CDT
Leader in firearm manufacturing, Sturm, Ruger & Co., Inc., has selected Sigmetrix CETOL 6 Sigma tolerance analysis software as part of its engineering arsenal.
RGR: 37.42 (-0.40)

Downtrend Call Working As Sturm Ruger & Co Stock Falls 16.3% (RGR)
Comtex SmarTrend(R) - Mon Oct 20, 5:02PM CDT
SmarTrend identified a Downtrend for Sturm Ruger & Co (NYSE:RGR) on May 21st, 2014 at $61.86. In approximately 5 months, Sturm Ruger & Co has returned 16.34% as of today's recent price of $51.75.
RGR: 37.42 (-0.40)

Sturm, Ruger & Company, Inc. Announces Q3 2014 Earnings Conference Call
GlobeNewswire - Wed Oct 15, 4:05PM CDT
Sturm, Ruger & Company, Inc. (NYSE:RGR) will hold its quarterly conference call to discuss the Company's third quarter 2014 results on Thursday, October 30, 2014, at 9:00 a.m. ET (8 a.m. Central Time).
RGR: 37.42 (-0.40)

Sturm, Ruger & Company, Inc. to Report Third Quarter Results on Wednesday, October 29
Business Wire - Wed Oct 15, 4:05PM CDT
Sturm, Ruger & Company, Inc. (NYSE:RGR) will announce its financial results for the third quarter and file its Quarterly Report on Form 10-Q on Wednesday, October 29, 2014, after the close of the stock market.
RGR: 37.42 (-0.40)

RSH, GDP, ESI, CGA, RGR, Removed From Naked Short Lists Today
M2 - Tue Oct 14, 9:58AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Removed From the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. RadioShack Corp (NYSE:RSH), Goodrich Petroleum Corp (NYSE:GDP), ITT EDUCATIONAL SERVICES INC (NYSE:ESI), China Green Agriculture Inc (NYSE:CGA), Sturm Ruger & Company Inc (NYSE:RGR). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
CGA: 1.98 (-0.04), GDP: 7.47 (-0.13), ESI: 10.02 (-0.39), RSH: 0.97 (-0.02), RGR: 37.42 (-0.40)

Sturm Ruger & Co Has Returned 26.0% Since SmarTrend Recommendation (RGR)
Comtex SmarTrend(R) - Mon Oct 13, 11:00AM CDT
SmarTrend identified a Downtrend for Sturm Ruger & Co (NYSE:RGR) on May 21st, 2014 at $61.86. In approximately 5 months, Sturm Ruger & Co has returned 25.97% as of today's recent price of $45.79.
RGR: 37.42 (-0.40)

ONEQ, RGR, DSEEY, Added To Naked Short Lists Today
M2 - Fri Oct 10, 9:28AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Fidelity Nasdaq Composite Index Tracking Stock (NASDAQ:ONEQ), Sturm Ruger & Company Inc (NYSE:RGR), Daiwa Securities Group Inc (OTC SEEY). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
ONEQ: 182.33 (+1.05), RGR: 37.42 (-0.40)

Cheap Stocks Wall Street Loves: Smith & Wesson
Sean Williams, The Motley Fool - Motley Fool - Mon Oct 06, 1:00PM CDT
If Doc Brown, one of the main characters in 1985's  Back to the Future,  had actually invented a time machine shareholders of firearms manufacturer Smith & Wesson would probably use it to go back in time and sell their shares in mid-June. As...
RGR: 37.42 (-0.40), SWHC: 10.06 (-0.10)

Shares of RGR Down 20.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 06, 9:44AM CDT
SmarTrend identified a Downtrend for Sturm Ruger & Co (NYSE:RGR) on May 21st, 2014 at $61.86. In approximately 5 months, Sturm Ruger & Co has returned 20.90% as of today's recent price of $48.93.
RGR: 37.42 (-0.40)

Sturm Ruger & Company (RGR) Stock Research Links

RGR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading